Phil Sobel, Head of Finance North America
Phil Sobel has been Head of North America Finance for Guerbet’s commercial business since November 2019. He is responsible for the oversight of Finance and Accounting of as well as financial planning and analysis activities.
Before joining Guerbet, Mr. Sobel was with Amneal Pharmaceuticals, where he was responsible for financial planning and analysis for the company’s global research and development activities. Preceding that, he was with the Sandoz division of Novartis, where he held several financial positions, including Head of Business Planning & Analysis (BPA) for the US division and Director BPA for Research & Development and Business Licensing & Development.
Mr. Sobel holds a B.S. degree from Bryant University, majoring in Accounting, and has completed management courses including several Finance Excellence programs.